The International Centre for Antimicrobial Resistance Solutions (ICARS)

📣 Consultancy Opportunity: Assessing AMR Interventions in the Caribbean 🗓️ Deadline: 10 February 2025 🖥️ Workplace: Remote 🌎 ICARS seeks to understand the landscape of public and private sector interventions in the CARICOM 10 region aimed at addressing antimicrobial resistance (AMR). 🔎 The objective of this consultancy is to provide a comprehensive assessment of AMR prevention and control interventions and to identify effective strategies, gaps, and opportunities for scaling and adaptation within the region. 📄 The findings will contribute to an evidence base for strengthened AMR policies, practices, and resources across agriculture, agri-food, and healthcare sectors. Learn more and apply ➡️ https://lnkd.in/d7jZ6XeM

📄 Today's #MondayRead is a paper on #Vaccines & #AMR that analyses the funding landscape for human bacterial vaccines in low- and middle-income countries (LMICs). Key findings: 💰 Funding disparity: Between 2007 and 2024, the Global North received the majority of human bacterial vaccine funding, while the Global South received less than 20% of the total. 🌎 Geographic misalignment: There is a mismatch between funding distribution and the burden of antimicrobial resistance (AMR). 📊 Data gaps: Current tracking lacks details on final funding recipients, hindering full assessment of inequities. 📉 Low domestic investment: Limited investment from LMICs further complicates efforts to address funding disparities. 🔎 Funding focus: Most funding targeted M. tuberculosis and S. pneumoniae, with critical gaps in R&D funding for WHO AMR priority pathogens. 🧫 Need for transparency: Transparent tracking, reporting, and allocation of vaccine R&D funding are essential for tackling AMR and addressing global health challenges effectively. Read more ➡️ https://bit.ly/40UF7fj Catherine Fleck-Vidal, Anna Doubell, Usha Lamichhane, Lesley Ogilvie, Ralf Sudbrak, Jerome Kim, T. Anh WARTEL, MD and Laura Plant #GlobalHealth #Vaccine #ResearchFunding

🌍 Bridging Policy and Action – A Post-UNGA One Health Agenda for AMR This Side Meeting, held in Bangkok during the Prince Mahidol Award Conference (PMAC) 2025, gathered regional and national experts, policymakers, civil society and other stakeholders to deliberate on Antimicrobial Resistance (#AMR) mitigation across the Asia-Pacific region. Co-organised by The International Centre for Antimicrobial Resistance Solutions (ICARS), the AMR Multistakeholder Partnership Platform, and the IHPP, the event built on the momentum from the 2024 United Nations General Assembly  High-Level Meeting on AMR to explore actionable strategies and solutions for implementing the declaration in the region. 💡 Key discussions included: 🔹 Strengthening #OneHealth approaches for cross-sector and in-sector collaboration 🔹 Leveraging regional coordination in mitigating efforts and financing for AMR response 🔹 Generation of actionable data that informs policies and strategies 🔹 Scaling and sharing of successful AMR interventions within and to other regions 🔹 Empowering civil society organisations (CSOs) & media to raise awareness and drive action 🤝 The event served as a critical platform for cross-sector collaboration and the exchange of knowledge to drive AMR solutions in the Asia-Pacific region. 🙏 ICARS warmly thanks all the speakers, participants, and organisers for making this event a success. Embassy of Denmark in Bangkok, Henning Høy Nygaard, Danny Annan, Kanokwan Kunanopparat, Benyamin Sihombing, Angkana Lekagul, Prof. Rungtip Chuanchuen, Dr Soawapak Hinjoy, AHM Bazlur Rahman, Specialist in Digital Democracy, Dr Scott Newman, Muhammad Usman Zaheer (DVM, PhD, Dipl. ACVPM, M.A.C.E.), Dr Tongkorn Meeyam, phoutsathaphone sibounheuang, Dr Julaporn Srinha, Kristina Osbjer, Theresa Hogenhaug, Jonathan Mayito, Julie Cassan 🔗 Read more ➡️ https://bit.ly/4hGdmgh #AMRPMAC2025 #SustainableHealth #GlobalHealth #PMAC2025 #AMRSolutions #HealthForAll

Together with Rwanda Biomedical Centre University of Rwanda The International Centre for Antimicrobial Resistance Solutions (ICARS) Institute of Tropical Medicine Antwerp Global-PPS Charité - Universitätsmedizin Berlin we are organising a #driveAMS masterclass in Kigali, Rwanda with AMS Stewards Acsa Igizeneza, Innocent Hahirwa, Claude Semuto, Leopold Bitunguhari and Lambert Safari. First step in implementation of #AMS programs in hospitals. Including SPICE support see https://lnkd.in/dmtqmGVZ For our philosophy see https://lnkd.in/dvfgWstS For our program see https://lnkd.in/dnDUTezf

📣 We're hiring for a Grant Manager/Officer at ICARS! 🗓️ Deadline: 14 February 2025 📍 Location: Copenhagen, Denmark ✅The successful candidate will play a vital role in ensuring the effective administration, monitoring, and reporting of external grants that will assist in mitigating antimicrobial resistance (AMR). 🌍 Working collaboratively with the ICARS team and external partners, the Grant Manager/Officer will manage external grant processes that support innovative, evidence-based projects in Low- and Middle-Income Countries (LMICs). 🔎 This role will focus on a key grant supporting impactful projects and activities across Africa, advancing sustainable solutions to AMR. Apply now ➡️https://lnkd.in/dhGuViMu #GrantManager #ICARS #AMR #GlobalHealth #FundingImpact

In the last few months, the World Health Organization and another group of researchers quantified the effect of vaccines on antimicrobial use. Both estimated the reduction in infections from (new) vaccines, and based on that the estimated reduction in antibiotic use - directly related to those prevented infections. The reductions are modest (a few percentages of all antibiotic use) since most antibiotics are not used in patients with actual bacterial infections. BUT the largest potential for improvements in antimicrobial use can not be addressed in such simulation studies: the effect on prescriber behaviour, determined by their uncertainty of the potential cause of disease. "If new Shigella, enterotoxigenic E coli, and non-Typhi Salmonella vaccines attain sufficient overall vaccine effectiveness and vaccination coverage, all bacterial pathogens that contribute most to the burden of diarrhoeal disease could be reduced, mitigating prescribers' uncertainty. Prescription protocols could also be simplified, allowing for more straightforward educational and persuasive antimicrobial stewardship interventions targeting prescribers and patients. Hence, not only antibiotic use for those bacteria-specific diarrhoeal episodes, but any antibiotic use to treat diarrhoeal episodes—nearly a quarter of all antibiotic use (135 of 577 antibiotic courses per 100 child-years)—could be avoided." -> there's a need for implementation research evaluating the combined and interacting effect of vaccination and behavioural interventions on antibiotic use, without overlooking prescribers' and patients' perceptions, uncertainty, and related behaviour. We tried to highlight that in a letter https://lnkd.in/e8-T5Qxs The International Centre for Antimicrobial Resistance Solutions (ICARS) Nandini Sreenivasan Annick Lenglet

Only two days left for our workshop on: 𝐌𝐞𝐚𝐬𝐮𝐫𝐞𝐬 𝐟𝐨𝐫 𝐑𝐞𝐝𝐮𝐜𝐢𝐧𝐠 𝐀𝐌𝐑 𝐁𝐮𝐫𝐝𝐞𝐧: 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲, 𝐏𝐨𝐥𝐢𝐜𝐲 & 𝐒𝐭𝐞𝐰𝐚𝐫𝐝𝐬𝐡𝐢𝐩 🗓️ 31st January, 2025 (Friday) 🕘 9:00 AM to 5 PM 📍 Indian Institute of Science Education and Research (IISER), Pune This workshop aims to bring together a wide range of #stakeholders from #academia, #industry, #government, and #nonprofit organizations to facilitate discussions on combating #AMR through innovative #solutions and #strategies. We have an interesting lineup of speakers who will talk about: 💡 Leveraging Technology & AI for AMR detection & management 💡 AMR, One Health & Policy 💡 Stewardship Programs & Capacity Building 💡 Methods & Tools for AMR surveillance & elimination If you have any questions for the speakers, kindly share them with us here: https://lnkd.in/g5sqT36H #AntimicrobialResistance #AMRWorkshop #InfectiousDiseases #HealthInnovation #PublicHealth #AntibioticResistance #OneHealth #MedicalResearch #DiseasePrevention #Researchers #Academicians #PublicPolicy #Industry #HealthcareEducation #ClinicalResearch Office of the Principal Scientific Adviser to the Government of India | Priya Nagaraj | Priyanki Shah | Niharika Gogate | Chaitra A Narayan | Rupali Shivapurkar, Ph.D. | Shreyas Khade | Mahesh Dharne | Rajeshwari Sinha, PhD | Rishiraj Bhagawati | Shridhar Narayanan | Somdatta Karak, PhD | Tavpritesh Sethi MBBS, PhD | Jagdish A K | Jyoti Joshi | Karan Prabhakar | Praapti Jayaswal, PhD | Ish Preet Singh | Sanjay Juvekar | Saurabh Sharma | Shraddha Karve | APSI-India

⌛ The deadline for submitting an Expression of Interest (EOI) to ICARS is the 15th of February 2025. ✅ The EOI is the first step for Ministries of Health, Agriculture, Environment etc. to indicate their interest in co-developing an intervention and implementation research project to help advance their National Action Plans for Antimicrobial Resistance. 🔎 To learn more about the process visit ➡️ https://lnkd.in/dFGH6eFi 📽️ Watch a short video about the ICARS co-development process ➡️ https://bit.ly/4axePmB #EOI #antimicrobialresistance #AMR #project #AnimalHealth #HumanHealth #Environment #OneHealth

🌐 There's still time to sign up for the online webinar! 🗓 January 29th, 2025 ⏰ 9:00 AM – 4:00 PM ICT ➡️ https://bit.ly/3WlRmPv #AMRPMAC2025

📄 Today's #MondayRead is the World Health Organization's updated AMR resource pack, providing useful materials for the development and implementation of national action plans (NAPs) on antimicrobial resistance (#AMR). 👏 The 2025 edition organises documents around a core package of 13 people-centred interventions. 🎯 These interventions serve as a foundation for prioritising and selecting activities for NAPs, following a programmatic approach that addresses health system challenges and barriers people face in accessing care. It also considers the interdependencies between AMR interventions to ensure a comprehensive response. Read more ➡️ https://bit.ly/4hxoCLO